Clinical Trial ID: NCT06319027
Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial
Status
Open
Conditions
Other
Phases
II
Age Group
Adult
Main Investiagtor
Cavaliere, Robert
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT06319027
Secondary Trial ID Number
EAF223
Keywords
Diagnostic